SMOFKABIVEN émuls perf 986ml sach 4 pce
7680606890026
CH-60689
B05BA10
07.01.2.
1 / 2
google
Details
- Product number
- 6068901
- CPT
- -
- Packaging group
- 4 x 986
- Unit
- ml
- Composition
- I) Glucoselösung 42 %: glucosum 125 g ut glucosum monohydricum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 298 ml. II) Aminosäurenlösung mit Elektrolyte: alaninum 7 g, argininum 6 g, glycinum 5.5 g, histidinum 1.5 g, isoleucinum 2.5 g, leucinum 3.7 g, lysinum anhydricum 3.3 g ut lysini acetas, methioninum 2.2 g, phenylalaninum 2.6 g, prolinum 5.6 g, serinum 3.2 g, taurinum 500 mg, threoninum 2.2 g, tryptophanum 1 g, tyrosinum 200 mg, valinum 3.1 g, calcii chloridum anhydricum 280 mg ut calcii chloridum dihydricum, natrii glycerophosphas 2.1 g, magnesii sulfas anhydricus 600 mg ut magnesii sulfas heptahydricus, kalii chloridum 2.2 g, natrii acetas 1.7 g ut natrii acetas trihydricus, zinci sulfas anhydricus 6.5 mg ut zinci sulfas heptahydricus, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 500 ml. III) Fettemulsion: sojae oleum raffinatum 11.3 g, triglycerida media 11.3 g, olivae oleum raffinatum 9.4 g, piscis oleum 5.6 g, int-rac-alpha-tocopherolum, phospholipida ex ovo purificata, glycerolum, natrii oleas, natrii hydroxidum, aqua ad iniectabile q.s. ad emulsionem pro 188 ml. . I) et II) et III) corresp.: aminoacida 50 g, nitrogenia 8 g, carbohydrata 125 g, materia crassa 38 g, natrium 40 mmol, kalium 30 mmol, magnesium 5 mmol, calcium 2.5 mmol, phosphas 12 mmol, zincum 0.04 mmol, sulfas 5 mmol, chloridum 35 mmol, acetas 104 mmol, in emulsione recenter mixta 986 ml. Corresp. 4600 kJ pro 986 ml.
Articles (1)
SmofKabiven, Infusionsemulsion 986 ml
Infusionsemulsion
4 x 986
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
II
|
7.0 G | Substance | Wirkstoff (Principe actif) |
|
I
|
125.0 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
50.0 G | Substance | Wirkstoff (Principe actif) |
|
III
|
11.3 G | Substance | Wirkstoff (Principe actif) |
|
III
|
11.3 G | Substance | Wirkstoff (Principe actif) |
|
II
|
6.0 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
8.0 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | WIZUS |
|
III
|
9.4 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
125.0 G | Substance | Wirkstoff (Principe actif) |
|
II
|
5.5 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
123C
|
38.0 G | Substance | Wirkstoff (Principe actif) |
|
III
|
5.6 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
II
|
1.5 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
40.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
2.5 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
123C
|
30.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
3.7 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
3.3 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
5.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
- | Substance | WIZUS |
|
123C
|
2.5 MMOL | Substance | Wirkstoff (Principe actif) |
|
123C
|
12.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
2.2 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
2.6 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
0.04 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
5.6 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
5.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
3.2 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
35.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
123C
|
104.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
2.2 G | Substance | Wirkstoff (Principe actif) |
|
II
|
1.0 G | Substance | Wirkstoff (Principe actif) |
|
II
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
3.1 G | Substance | Wirkstoff (Principe actif) |
|
II
|
280.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
2.1 G | Substance | Wirkstoff (Principe actif) |
|
II
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
2.2 G | Substance | Wirkstoff (Principe actif) |
|
II
|
1.7 G | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
6.5 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 60689
- Drug name
- SmofKabiven, Infusionsemulsion
- Galenic form
- EMUI
- ATC Code
- B05BA10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 26/01/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.01.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SMOFKABIVEN émuls perf 986ml sach 4 pce
- Description (DE)
- SMOFKABIVEN Inf Emuls 986ml Btl 4 Stk
- Market launch
- 26/01/2011
- Narcotic (BTM)
- No